YS Biopharma Co., Ltd. (YS)
(Delayed Data from NSDQ)
$0.98 USD
+0.02 (2.08%)
Updated May 21, 2024 03:59 PM ET
After-Market: $0.98 0.00 (0.00%) 6:08 PM ET
4-Sell of 5 4
C Value B Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO4/19/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.45 |
Next Year | -0.25 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.82M | 24.27M | 82.30M | 109.20M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 21.82M | 24.27M | 82.30M | 109.20M |
Low Estimate | 21.82M | 24.27M | 82.30M | 109.20M |
Year ago Sales | NA | 24.40M | 100.00M | 82.30M |
Year over Year Growth Est. | NA | -0.53% | -17.70% | 32.69% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.09 | -0.45 | -0.25 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.08 | -0.09 | -0.45 | -0.25 |
High Estimate | -0.08 | -0.09 | -0.45 | -0.25 |
Low Estimate | -0.08 | -0.09 | -0.45 | -0.25 |
Year ago EPS | NA | -0.10 | NA | -0.45 |
Year over Year Growth Est. | NA | 10.00% | NA | 44.44% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.09 | -0.45 | -0.25 |
7 Days Ago | -0.08 | -0.09 | -0.45 | -0.25 |
30 Days Ago | -0.06 | -0.05 | -0.24 | -0.15 |
60 Days Ago | -0.06 | -0.05 | -0.24 | -0.15 |
90 Days Ago | -0.11 | -0.11 | -0.49 | -0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.09 | -0.45 | -0.25 |
Zacks Consensus Estimate | -0.08 | -0.09 | -0.45 | -0.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.16 | -0.10 | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more